Ipilimumab plus nivolumab versus nivolumab alone in patients with melanoma brain metastases (ABC): 7-year follow-up of a multicentre, open-label, randomised, phase 2 study

Georgina V. Long; Victoria Atkinson; Serigne Lo; Alexander Guminski; Shahneen Sandhu; Michael P. Brown; Maria Gonzalez; Grant A. McArthur; Alexander M Menzies

doi:10.1016/s1470-2045(24)00735-6

Related publications

Article2018

Combination nivolumab and ipilimumab or nivolumab alone in melanoma brain metastases: a multicentre randomised phase 2 study

Georgina V. Long, Victoria Atkinson, Serigne Lo, Shahneen Sandhu, Alexander Guminski, Michael P. Brown, James S. Wilmott, Jarem Edwards, Maria Gonzalez, Richard A. Scolyer, Alexander M. Menzies, Grant A. McArthur

Article2016

A randomized phase 2 study of nivolumab and nivolumab combined with ipilimumab in patients (pts) with melanoma brain metastases: The Anti-PD1 Brain Collaboration (ABC Study).

Georgina V. Long, Victoria Atkinson, Alexander M. Menzies, Alexander Guminski, Shahneen Sandhu, Michael P. Brown, Tracy T.Y.E. Liaw, Maria Gonzalez, Jill Davison, Elizabeth Paton, Richard A. Scolyer, Louise Emmett, Grant A. McArthur

Article2017

A randomized phase II study of nivolumab or nivolumab combined with ipilimumab in patients (pts) with melanoma brain metastases (mets): The Anti-PD1 Brain Collaboration (ABC).

Georgina V. Long, Victoria Atkinson, Alexander M. Menzies, Serigne Lo, Alexander Guminski, Michael P. Brown, M. M. González, Katrina Diamante, Shahneen Sandhu, Richard A. Scolyer, Louise Emmett, Grant A. McArthur

Article2021

Five-year overall survival from the anti-PD1 brain collaboration (ABC Study): Randomized phase 2 study of nivolumab (nivo) or nivo+ipilimumab (ipi) in patients (pts) with melanoma brain metastases (mets).

Georgina V. Long, Victoria Atkinson, Serigne Lo, Alexander Guminski, Shahneen Sandhu, Michael P. Brown, Maria Gonzalez, Richard A. Scolyer, Louise Emmett, Grant A. McArthur, Alexander M. Menzies

Article2020

Preoperative radiotherapy plus surgery versus surgery alone for patients with primary retroperitoneal sarcoma (EORTC-62092: STRASS): a multicentre, open-label, randomised, phase 3 trial

Sylvie Bonvalot, Alessandro Gronchi, C. Le Péchoux, Carol J. Swallow, D. Strauß, Pierre Méeus, Frits van Coevorden, Stephan Stoldt, Eberhard Stoeckle, Piotr Rutkowski, Marco Rastrelli, Chandrajit P. Raut, Daphne Hompes, Antonino De Paoli, Claudia Sangalli, Charles Honoré, Peter Chung, Aisha Miah, Jean Yves Blay, Marco Fiore, Jean‐Jacques Stelmes,